Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
713.5 GBX | -0.97% | +2.15% | -5.06% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | Pennon seeks to allay CMA's concerns over South West Water acquisition | AN |
Sales 2024 * | 881M 1.1B | Sales 2025 * | 943M 1.18B | Capitalization | 2.04B 2.55B |
---|---|---|---|---|---|
Net income 2024 * | 23M 28.8M | Net income 2025 * | 62M 77.63M | EV / Sales 2024 * | 6.27 x |
Net Debt 2024 * | 3.49B 4.37B | Net Debt 2025 * | 3.84B 4.81B | EV / Sales 2025 * | 6.24 x |
P/E ratio 2024 * |
112
x | P/E ratio 2025 * |
45.5
x | Employees | - |
Yield 2024 * |
6.31% | Yield 2025 * |
6.56% | Free-Float | 99.53% |
Latest transcript on Pennon Group Plc
1 day | -0.97% | ||
1 week | +2.15% | ||
Current month | +7.21% | ||
1 month | +12.98% | ||
3 months | +8.77% | ||
6 months | -1.45% | ||
Current year | -5.06% |
Managers | Title | Age | Since |
---|---|---|---|
Susan Davy
CEO | Chief Executive Officer | 55 | 15-01-31 |
Steve Buck
DFI | Director of Finance/CFO | - | Nov. 26 |
Richard Price
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gill Rider
CHM | Chairman | 68 | 12-08-31 |
Susan Davy
CEO | Chief Executive Officer | 55 | 15-01-31 |
Director/Board Member | 56 | 22-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 713.5 | -0.97% | 476,347 |
24-05-09 | 720.5 | +1.34% | 440,006 |
24-05-08 | 711 | -0.77% | 647,929 |
24-05-07 | 716.5 | +2.58% | 763,941 |
24-05-03 | 698.5 | +1.38% | 754,502 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.06% | 2.55B | |
+4.03% | 10.4B | |
+5.06% | 10.73B | |
+0.31% | 9.68B | |
+3.30% | 9.34B | |
+31.63% | 3.08B | |
+2.47% | 3.07B | |
+8.92% | 2.98B | |
-3.03% | 2.9B | |
-0.53% | 1.84B |
- Stock Market
- Equities
- PNN Stock